Search Results 11-20 of 16259 for intestinal metaplasia
-
This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...
-
... metaplasia, dysplasia, or EAC versus patients who ... bowel and colon in subjects with known CD and mucosal disease. ... A Study to Compare COVID-19 Nasal Testing ...
-
... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...
-
Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.
-
... intestinal metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies ...
-
... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...
-
"Our results suggest the existence of an alternative pathway — one in which metaplasia progresses rapidly to EAC , with or without intestinal metaplasia," says ...
-
... intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's ...
-
Familial adenomatous polyposis also can cause adenomas. Regular use of certain stomach medicines. Fundic gland polyps are common among people who regularly take ...
-
Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus. Gastrointest Endosc. 2019 Apr; 89 (4):759-768 ...